TW200523534A - Multiple laminar flow-based particle and cellular separation with laser steering - Google Patents
Multiple laminar flow-based particle and cellular separation with laser steering Download PDFInfo
- Publication number
- TW200523534A TW200523534A TW093126848A TW93126848A TW200523534A TW 200523534 A TW200523534 A TW 200523534A TW 093126848 A TW093126848 A TW 093126848A TW 93126848 A TW93126848 A TW 93126848A TW 200523534 A TW200523534 A TW 200523534A
- Authority
- TW
- Taiwan
- Prior art keywords
- flow
- component
- cells
- blood
- components
- Prior art date
Links
- 238000000926 separation method Methods 0.000 title claims abstract description 183
- 230000001413 cellular effect Effects 0.000 title claims abstract description 15
- 239000002245 particle Substances 0.000 title description 84
- 230000003287 optical effect Effects 0.000 claims abstract description 296
- 239000000306 component Substances 0.000 claims abstract description 238
- 238000000034 method Methods 0.000 claims abstract description 168
- 210000004369 blood Anatomy 0.000 claims abstract description 101
- 239000008280 blood Substances 0.000 claims abstract description 100
- 239000012503 blood component Substances 0.000 claims abstract description 38
- 210000004027 cell Anatomy 0.000 claims description 274
- 239000012530 fluid Substances 0.000 claims description 173
- 239000000463 material Substances 0.000 claims description 68
- 210000001772 blood platelet Anatomy 0.000 claims description 51
- 210000000265 leukocyte Anatomy 0.000 claims description 39
- 238000001556 precipitation Methods 0.000 claims description 36
- 210000000601 blood cell Anatomy 0.000 claims description 34
- 210000003743 erythrocyte Anatomy 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 33
- 239000000126 substance Substances 0.000 claims description 19
- 230000000694 effects Effects 0.000 claims description 18
- 238000009792 diffusion process Methods 0.000 claims description 15
- 230000033001 locomotion Effects 0.000 claims description 14
- 230000035558 fertility Effects 0.000 claims description 13
- 239000003146 anticoagulant agent Substances 0.000 claims description 11
- 229940127219 anticoagulant drug Drugs 0.000 claims description 11
- 230000006378 damage Effects 0.000 claims description 11
- 239000000356 contaminant Substances 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 8
- 238000001228 spectrum Methods 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 6
- 238000000638 solvent extraction Methods 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 5
- 238000011161 development Methods 0.000 claims description 5
- 238000004062 sedimentation Methods 0.000 claims description 5
- 239000003344 environmental pollutant Substances 0.000 claims description 4
- 208000021267 infertility disease Diseases 0.000 claims description 4
- 231100000719 pollutant Toxicity 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 3
- 208000014674 injury Diseases 0.000 claims description 3
- 238000005192 partition Methods 0.000 claims description 3
- 239000000701 coagulant Substances 0.000 claims description 2
- 238000005194 fractionation Methods 0.000 claims description 2
- 230000002452 interceptive effect Effects 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims 2
- 235000013619 trace mineral Nutrition 0.000 claims 2
- 239000011573 trace mineral Substances 0.000 claims 2
- 230000009286 beneficial effect Effects 0.000 claims 1
- 230000003134 recirculating effect Effects 0.000 claims 1
- 238000000920 holographic laser trapping Methods 0.000 abstract description 2
- 238000000651 laser trapping Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 60
- 239000000243 solution Substances 0.000 description 46
- 230000008569 process Effects 0.000 description 31
- 239000002609 medium Substances 0.000 description 22
- 230000005684 electric field Effects 0.000 description 19
- 230000008901 benefit Effects 0.000 description 17
- 238000005516 engineering process Methods 0.000 description 17
- 239000002699 waste material Substances 0.000 description 17
- 210000002381 plasma Anatomy 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- 230000000875 corresponding effect Effects 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 238000000605 extraction Methods 0.000 description 11
- 238000003384 imaging method Methods 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 230000003068 static effect Effects 0.000 description 11
- 239000012620 biological material Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000004590 computer program Methods 0.000 description 10
- 208000031513 cyst Diseases 0.000 description 10
- 238000010586 diagram Methods 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- 241000700605 Viruses Species 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 239000004973 liquid crystal related substance Substances 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 238000005286 illumination Methods 0.000 description 6
- 230000002147 killing effect Effects 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 235000012489 doughnuts Nutrition 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000000149 penetrating effect Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 238000004611 spectroscopical analysis Methods 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000003850 cellular structure Anatomy 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 210000004153 islets of langerhan Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000004575 stone Substances 0.000 description 4
- -1 CDNA Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000007885 magnetic separation Methods 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000010349 pulsation Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000035602 clotting Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000004904 fingernail bed Anatomy 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000012576 optical tweezer Methods 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 230000033458 reproduction Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010051728 Bone erosion Diseases 0.000 description 1
- 241000761427 Boraras micros Species 0.000 description 1
- 230000005653 Brownian motion process Effects 0.000 description 1
- 208000003870 Drug Overdose Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 239000004988 Nematic liquid crystal Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033296 Overdoses Diseases 0.000 description 1
- 101000882917 Penaeus paulensis Hemolymph clottable protein Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000005537 brownian motion Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000000701 chemical imaging Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 238000004720 dielectrophoresis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 231100000725 drug overdose Toxicity 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002433 mononuclear leukocyte Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000004508 polar body Anatomy 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000007261 regionalization Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C5/00—Separating dispersed particles from liquids by electrostatic effect
- B03C5/005—Dielectrophoresis, i.e. dielectric particles migrating towards the region of highest field strength
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/0005—Field flow fractionation
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H3/00—Production or acceleration of neutral particle beams, e.g. molecular or atomic beams
- H05H3/04—Acceleration by electromagnetic wave pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/02—Electrostatic separation of liquids from liquids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/18—Magnetic separation whereby the particles are suspended in a liquid
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/04—Processes or apparatus for producing holograms
- G03H1/08—Synthesising holograms, i.e. holograms synthesized from objects or objects from holograms
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/22—Processes or apparatus for obtaining an optical image from holograms
- G03H1/2294—Addressing the hologram to an active spatial light modulator
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/0005—Adaptation of holography to specific applications
- G03H2001/0077—Adaptation of holography to specific applications for optical manipulation, e.g. holographic optical tweezers [HOT]
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03H—HOLOGRAPHIC PROCESSES OR APPARATUS
- G03H1/00—Holographic processes or apparatus using light, infrared or ultraviolet waves for obtaining holograms or for obtaining an image from them; Details peculiar thereto
- G03H1/04—Processes or apparatus for producing holograms
- G03H1/08—Synthesising holograms, i.e. holograms synthesized from objects or objects from holograms
- G03H1/0841—Encoding method mapping the synthesized field into a restricted set of values representative of the modulator parameters, e.g. detour phase coding
- G03H2001/085—Kinoform, i.e. phase only encoding wherein the computed field is processed into a distribution of phase differences
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Electromagnetism (AREA)
- Pathology (AREA)
- Pregnancy & Childbirth (AREA)
- Plasma & Fusion (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Electrochemistry (AREA)
- Molecular Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49995703P | 2003-09-04 | 2003-09-04 | |
| US51145803P | 2003-10-15 | 2003-10-15 | |
| US57114104P | 2004-05-14 | 2004-05-14 | |
| US10/867,328 US7150834B2 (en) | 2003-07-31 | 2004-06-13 | Multiple laminar flow-based rate zonal or isopycnic separation with holographic optical trapping of blood cells and other static components |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200523534A true TW200523534A (en) | 2005-07-16 |
Family
ID=52347979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093126848A TW200523534A (en) | 2003-09-04 | 2004-09-03 | Multiple laminar flow-based particle and cellular separation with laser steering |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1663460B1 (https=) |
| JP (6) | JP5046645B2 (https=) |
| TW (1) | TW200523534A (https=) |
| WO (1) | WO2005023391A2 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113498362A (zh) * | 2019-02-27 | 2021-10-12 | 京瓷株式会社 | 粒子分离测量设备以及粒子分离测量装置 |
| TWI819025B (zh) * | 2018-07-11 | 2023-10-21 | 日商愛宕股份有限公司 | 黏度計 |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11243494B2 (en) | 2002-07-31 | 2022-02-08 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
| GB2429996B (en) | 2003-02-26 | 2007-08-29 | Enventure Global Technology | Apparatus for radially expanding and plastically deforming a tubular member |
| WO2009035623A1 (en) * | 2007-09-11 | 2009-03-19 | Arryx, Inc. | Binding method and apparatus for sorting objects |
| WO2009035621A1 (en) * | 2007-09-13 | 2009-03-19 | Arryx, Inc. | Methods and apparatuses for sorting objects in forensic dna analysis and medical diagnostics |
| US9364831B2 (en) | 2009-08-08 | 2016-06-14 | The Regents Of The University Of California | Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting |
| SG10201912164UA (en) * | 2010-11-16 | 2020-02-27 | 1087 Systems Inc | System for identifying and sorting living cells |
| US8941062B2 (en) | 2010-11-16 | 2015-01-27 | 1087 Systems, Inc. | System for identifying and sorting living cells |
| US10908066B2 (en) | 2010-11-16 | 2021-02-02 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
| US20120225475A1 (en) | 2010-11-16 | 2012-09-06 | 1087 Systems, Inc. | Cytometry system with quantum cascade laser source, acoustic detector, and micro-fluidic cell handling system configured for inspection of individual cells |
| US9176504B2 (en) * | 2011-02-11 | 2015-11-03 | The Regents Of The University Of California | High-speed on demand droplet generation and single cell encapsulation driven by induced cavitation |
| JP2015503736A (ja) * | 2011-12-29 | 2015-02-02 | ダンマークス テクニスク ユニバーシテット | 電磁放射を用いて微小物体を分類するためのシステム |
| WO2013128561A1 (ja) * | 2012-02-28 | 2013-09-06 | 株式会社メニコン | 細胞取扱用具 |
| US9545472B2 (en) * | 2012-03-02 | 2017-01-17 | Medtronic, Inc. | Extracorporeal blood circuit reservoir with angled venous inlet luer port |
| EP2972405B1 (en) | 2013-03-15 | 2020-12-23 | The Regents of The University of California | High-speed on demand microfluidic droplet generation and manipulation |
| US8961904B2 (en) | 2013-07-16 | 2015-02-24 | Premium Genetics (Uk) Ltd. | Microfluidic chip |
| KR20150014781A (ko) | 2013-07-30 | 2015-02-09 | 삼성전자주식회사 | 유체를 여과하기 위한 장치 및 그를 이용한 입자를 분리하는 방법 |
| US11796449B2 (en) | 2013-10-30 | 2023-10-24 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
| GB2528632A (en) * | 2014-04-30 | 2016-02-03 | Cambridge Entpr Ltd | Fluidic analysis and separation |
| KR101984559B1 (ko) * | 2014-08-20 | 2019-05-31 | 스템 셀 에스.알.엘. | 대상물의 분류를 위한 장치 및 분류 방법 |
| US11708556B2 (en) | 2014-10-20 | 2023-07-25 | University Of Utah Research Foundation | Tissue sample processing system and associated methods |
| DK3314123T3 (da) * | 2015-06-23 | 2024-04-29 | Nanocellect Biomedical Inc | Systemer, apparater og fremgangsmåder til cellesortering og flowcytometri |
| JP6762695B2 (ja) * | 2015-09-18 | 2020-09-30 | 浜松ホトニクス株式会社 | 流路装置 |
| WO2018080997A1 (en) * | 2016-10-24 | 2018-05-03 | Gpb Scientific, Llc | Deterministic lateral displacement in the preparation of cells and compositions for therapeutic uses |
| WO2018235634A1 (ja) * | 2017-06-21 | 2018-12-27 | 株式会社ニコン | 流体デバイス及びその使用 |
| ES2774703T3 (es) * | 2017-06-27 | 2020-07-22 | Univ Graz Medizinische | Método y dispositivo para analizar una muestra fluídica con partículas dispersadas |
| EP3796998A1 (en) | 2018-05-23 | 2021-03-31 | ABS Global, Inc. | Systems and methods for particle focusing in microchannels |
| JP2020082047A (ja) * | 2018-11-30 | 2020-06-04 | シスメックス株式会社 | 分離成否判定方法、粒子検出方法および粒子分離装置 |
| WO2020128561A1 (en) | 2018-12-21 | 2020-06-25 | Premium Genetics (Uk) Ltd. | System and methods for sub-population identification |
| JP7212886B2 (ja) * | 2019-03-22 | 2023-01-26 | 国立研究開発法人産業技術総合研究所 | 受精用精子液の製造方法及び凍結精子ストローの製造方法 |
| EP3955735B1 (en) | 2019-04-18 | 2024-05-22 | ABS Global, Inc. | System and process for continuous addition of cryoprotectant |
| KR102266834B1 (ko) * | 2019-08-13 | 2021-06-17 | 경희대학교 산학협력단 | 정자 처리를 위한 미세유체장치 |
| US11628439B2 (en) | 2020-01-13 | 2023-04-18 | Abs Global, Inc. | Single-sheath microfluidic chip |
| WO2021225157A1 (ja) | 2020-05-08 | 2021-11-11 | 公立大学法人大阪 | 微小物体の検出装置、検出システムおよび検出方法 |
| JP2020157295A (ja) * | 2020-06-10 | 2020-10-01 | 浜松ホトニクス株式会社 | 流路装置 |
| US12573766B2 (en) | 2020-06-16 | 2026-03-10 | 3M Innovative Properties Company | Patterned article including metallic bodies |
| EP4232601A4 (en) | 2020-10-21 | 2024-10-09 | ABS Global, Inc. | METHODS AND SYSTEMS FOR PROCESSING GENETIC SAMPLES TO DETERMINE IDENTITY OR DETECT CONTAMINATION |
| JP7633402B2 (ja) | 2020-11-23 | 2025-02-19 | エイビーエス グローバル、インコーポレイテッド | モジュール式フロー・サイトメトリ・システム及びサンプル処理方法 |
| USD1118965S1 (en) | 2021-11-12 | 2026-03-17 | Abs Global, Inc. | Flow cytometry device |
| KR102763665B1 (ko) * | 2022-05-19 | 2025-02-06 | 단국대학교 산학협력단 | 정자 성별 분류장치 |
| KR102763666B1 (ko) * | 2022-05-26 | 2025-02-06 | 단국대학교 산학협력단 | 정자 성별 분류장치 |
| KR20240123023A (ko) * | 2023-02-06 | 2024-08-13 | 주식회사 그리니쉬 | 정자 선별 장치 및 정자 선별 방법 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57131451A (en) * | 1981-02-05 | 1982-08-14 | Asahi Chemical Ind | Method and apparatus for separating blood components |
| JPS5890513A (ja) * | 1981-11-26 | 1983-05-30 | Asahi Chem Ind Co Ltd | 血液成分の分取法および分取装置 |
| US4765899A (en) * | 1983-10-11 | 1988-08-23 | E. I. Du Pont De Nemours And Company | Apparatus for continuous separation of leukocyte/platelet-enriched fraction from whole blood |
| JP2777385B2 (ja) * | 1988-11-30 | 1998-07-16 | 株式会社日立製作所 | 生物細胞の培養方法，培養システム及び培養装置 |
| GB9003253D0 (en) * | 1990-02-13 | 1990-04-11 | Amersham Int Plc | Precipitating polymers |
| JPH0427866A (ja) * | 1990-05-23 | 1992-01-30 | Omron Corp | 細胞選別装置 |
| JPH0526799A (ja) * | 1991-07-19 | 1993-02-02 | Nippon Steel Corp | 微粒子の分離方法 |
| JPH0724309A (ja) * | 1993-07-08 | 1995-01-27 | Canon Inc | 粒子の分離方法及び装置 |
| US6797942B2 (en) * | 2001-09-13 | 2004-09-28 | University Of Chicago | Apparatus and process for the lateral deflection and separation of flowing particles by a static array of optical tweezers |
| US5716852A (en) * | 1996-03-29 | 1998-02-10 | University Of Washington | Microfabricated diffusion-based chemical sensor |
| US5932100A (en) * | 1995-06-16 | 1999-08-03 | University Of Washington | Microfabricated differential extraction device and method |
| US5948684A (en) * | 1997-03-31 | 1999-09-07 | University Of Washington | Simultaneous analyte determination and reference balancing in reference T-sensor devices |
| EP0910474B1 (en) * | 1996-06-14 | 2004-03-24 | University of Washington | Absorption-enhanced differential extraction method |
| JP2002503334A (ja) * | 1996-09-04 | 2002-01-29 | テクニカル ユニバーシティ オブ デンマーク | 粒子の分離と分析用のマイクロフローシステム |
| NZ336397A (en) * | 1997-01-08 | 2001-01-26 | Bristol Myers Squibb Co | Centrifuge apparatus comprising a piston displaceable in a cylindrical member and an optical blood cell detector |
| US6071689A (en) * | 1997-12-31 | 2000-06-06 | Xy, Inc. | System for improving yield of sexed embryos in mammals |
| DE19810195A1 (de) * | 1998-03-10 | 1999-09-23 | Reinhard Salinger | Verfahren und Vorrichtung zur Sammlung und Weiterverarbeitung von spezifischen Blutkomponenten bei kontinuierlichen laminaren Strömungsverhältnissen |
| DK2258170T3 (en) * | 2000-05-09 | 2017-10-16 | Xy Llc | X-chromosome-bearing and Y-chromosome-bearing populations of high purity spermatozoa |
| US20020160470A1 (en) * | 2000-11-13 | 2002-10-31 | Genoptix | Methods and apparatus for generating and utilizing linear moving optical gradients |
| US20030007894A1 (en) * | 2001-04-27 | 2003-01-09 | Genoptix | Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles |
| WO2002093202A2 (en) * | 2001-05-14 | 2002-11-21 | Arryx, Inc. | Improved apparatus, system and method for applying optical gradient forces |
-
2004
- 2004-09-03 JP JP2006525516A patent/JP5046645B2/ja not_active Expired - Fee Related
- 2004-09-03 EP EP04783338.9A patent/EP1663460B1/en not_active Expired - Lifetime
- 2004-09-03 WO PCT/US2004/029053 patent/WO2005023391A2/en not_active Ceased
- 2004-09-03 TW TW093126848A patent/TW200523534A/zh unknown
-
2010
- 2010-11-16 JP JP2010256249A patent/JP5160622B2/ja not_active Expired - Fee Related
-
2011
- 2011-09-14 JP JP2011200448A patent/JP5250674B2/ja not_active Expired - Fee Related
- 2011-11-24 JP JP2011256171A patent/JP5789178B2/ja not_active Expired - Fee Related
-
2015
- 2015-04-28 JP JP2015091320A patent/JP6154425B2/ja not_active Expired - Fee Related
-
2016
- 2016-09-23 JP JP2016185743A patent/JP6592414B2/ja not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI819025B (zh) * | 2018-07-11 | 2023-10-21 | 日商愛宕股份有限公司 | 黏度計 |
| CN113498362A (zh) * | 2019-02-27 | 2021-10-12 | 京瓷株式会社 | 粒子分离测量设备以及粒子分离测量装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5789178B2 (ja) | 2015-10-07 |
| EP1663460A4 (en) | 2008-01-09 |
| WO2005023391A3 (en) | 2005-12-01 |
| JP2011079842A (ja) | 2011-04-21 |
| JP2012020149A (ja) | 2012-02-02 |
| WO2005023391A2 (en) | 2005-03-17 |
| JP6592414B2 (ja) | 2019-10-16 |
| EP1663460B1 (en) | 2015-07-08 |
| JP2017026629A (ja) | 2017-02-02 |
| HK1092409A1 (en) | 2007-02-09 |
| JP5046645B2 (ja) | 2012-10-10 |
| JP6154425B2 (ja) | 2017-06-28 |
| JP5160622B2 (ja) | 2013-03-13 |
| HK1098980A1 (zh) | 2007-08-03 |
| JP2015164935A (ja) | 2015-09-17 |
| JP2007515936A (ja) | 2007-06-21 |
| EP1663460A2 (en) | 2006-06-07 |
| JP2012073268A (ja) | 2012-04-12 |
| JP5250674B2 (ja) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200523534A (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
| US11422504B2 (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
| US10216144B2 (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
| US7402131B2 (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
| EP2492011A1 (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
| HK1092409B (en) | Multiple laminar flow-based particle and cellular separation with laser steering | |
| HK1098980B (en) | Multiple laminar flow-based particle and cellular separation with laser steering |